Combining TMS and Ketamine for Treatment-Resistant Depression: Clinical Rationale, Current Evidence, and Practical Guidance.
Focus (Am Psychiatr Publ) July 8, 2026 DOI: 10.1176/appi.focus.20260014 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Depression Esketamine Ketamine |
| Key findings | Argues that combining TMS and ketamine for treatment-resistant depression is clinically rational and shows preliminary promise, but current evidence is limited and more rigorous research is needed to confirm efficacy and guide clinical use. |
Abstract
Combining TMS and Ketamine for Treatment-Resistant Depression: Clinical Rationale, Current Evidence, and Practical Guidance.